| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/08/10 | 04 : 49 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | NYSE:GS-J | Goldman Sachs Group Inc |
| 2024/08/10 | 04 : 49 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | AMEX:AMJB | Alerian Mlp Index ETNs due January 28 2044 |
| 2024/08/10 | 04 : 49 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACORQ | Acorda Therapeutics Inc (PK) |
| 2024/08/10 | 04 : 49 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | AMEX:AMJB | Alerian Mlp Index ETNs due January 28 2044 |
| 2024/08/10 | 04 : 49 | PR Newswire (Canada) | Notice - XIAO HUA (EDWARD) GONG, File No. 2022-14 | | |
| 2024/08/10 | 04 : 48 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACORQ | Acorda Therapeutics Inc (PK) |
| 2024/08/10 | 04 : 48 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACORQ | Acorda Therapeutics Inc (PK) |
| 2024/08/10 | 04 : 48 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | AMEX:VXZ | iPath Series B S&P 500 VIX MidTerm Futures ETN |
| 2024/08/10 | 04 : 46 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | NYSE:TD | Toronto Dominion Bank |
| 2024/08/10 | 04 : 46 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACORQ | Acorda Therapeutics Inc (PK) |
| 2024/08/10 | 04 : 45 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACORQ | Acorda Therapeutics Inc (PK) |
| 2024/08/10 | 04 : 45 | Edgar (US Regulatory) | Form N-CSRS - Certified Shareholder Report, Semi-Annual | NYSE:SRV | NXG Cushing Midstream Energy Fund |
| 2024/08/10 | 04 : 45 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:ACORQ | Acorda Therapeutics Inc (PK) |
| 2024/08/10 | 04 : 45 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NYSE:KEX | Kirby Corporation |
| 2024/08/10 | 04 : 44 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | AMEX:VXZ | iPath Series B S&P 500 VIX MidTerm Futures ETN |
| 2024/08/10 | 04 : 44 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACORQ | Acorda Therapeutics Inc (PK) |
| 2024/08/10 | 04 : 44 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | AMEX:AMJB | Alerian Mlp Index ETNs due January 28 2044 |
| 2024/08/10 | 04 : 43 | Cointelegraph | Will the Harris-Walz presidential campaign prioritize crypto policy? | COIN:BTCUSD | Bitcoin |
| 2024/08/10 | 04 : 43 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:ACORQ | Acorda Therapeutics Inc (PK) |
| 2024/08/10 | 04 : 43 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | NYSE:BML-L | Bank of America Corporation |
| 2024/08/10 | 04 : 42 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACORQ | Acorda Therapeutics Inc (PK) |
| 2024/08/10 | 04 : 42 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | AMEX:AMJB | Alerian Mlp Index ETNs due January 28 2044 |
| 2024/08/10 | 04 : 41 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:ACORQ | Acorda Therapeutics Inc (PK) |
| 2024/08/10 | 04 : 41 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:TPST | Tempest Therpeutics Inc |
| 2024/08/10 | 04 : 41 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:TRST | TrustCo Bank Corporation of NY |
| 2024/08/10 | 04 : 39 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | USOTC:SLGD | Scotts Liquid Gold Inc (PK) |
| 2024/08/10 | 04 : 39 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:ACORQ | Acorda Therapeutics Inc (PK) |
| 2024/08/10 | 04 : 39 | PR Newswire (US) | FDA Roundup: August 9, 2024 | | |
| 2024/08/10 | 04 : 38 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:ACORQ | Acorda Therapeutics Inc (PK) |
| 2024/08/10 | 04 : 38 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | AMEX:VXZ | iPath Series B S&P 500 VIX MidTerm Futures ETN |